|
1
|
Tran CM, Kuroshima T, Oikawa Y, Michi Y,
Kayamori K and Harada H: Clinicopathological and
immunohistochemical characteristics of pigmented oral squamous cell
carcinoma. Oncol Lett. 21(339)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hussein HA and Khaphi FL: The apoptotic
activity of curcumin against oral cancer cells without affecting
normal cells in comparison to paclitaxel activity. Appl Biochem
Biotechnol. 195:5019–5033. 2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Khaphi FL and Hussein HA: A preliminary
study of oral manifestations in cancer patients receiving
chemotherapy at basrah tumor center. J Adv Sci Nanotechnol.
2:173–181. 2023.
|
|
4
|
Feller L and Lemmer J: Oral squamous cell
carcinoma: Epidemiology, clinical presentation and treatment. J
Cancer Ther. 3:263–268. 2012.
|
|
5
|
Mesgari H, Esmaelian S, Nasiri K,
Ghasemzadeh S, Doroudgar P and Payandeh Z: Epigenetic regulation in
oral squamous cell carcinoma microenvironment: A comprehensive
review. Cancers (Basel). 15(5600)2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rai HC and Ahmed J: Clinicopathological
correlation study of oral squamous cell carcinoma in a local Indian
population. Asian Pac J Cancer Prev. 17:1251–1254. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jagtap MM, Shukla S, Acharya S, Tamhane A
and Bhake A: Utility of histochemical and immunohistochemical
profile in grading of squamous cell carcinoma of the oral cavity. J
Clin Diagn Res. 11:223–228. 2023.
|
|
8
|
Pekarek L, Garrido-Gil MJ, Sánchez-Cendra
A, Cassinello J, Pekarek T, Fraile-Martinez O, García-Montero C,
Lopez-Gonzalez L, Rios-Parra A, Álvarez-Mon M, et al: Emerging
histological and serological biomarkers in oral squamous cell
carcinoma: Applications in diagnosis, prognosis evaluation and
personalized therapeutics (Review). Oncol Rep.
50(213)2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pulte D and Brenner H: Changes in survival
in head and neck cancers in the late 20th and early 21st century: A
period analysis. Oncologist. 15:994–1001. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S,
Nice EC, Tang J and Huang C: Oral squamous cell carcinomas: State
of the field and emerging directions. Int J Oral Sci.
15(44)2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sim YC, Hwang JH and Ahn KM: Overall and
disease-specific survival outcomes following primary surgery for
oral squamous cell carcinoma: Analysis of consecutive 67 patients.
J Korean Assoc Oral Maxillofac Surg. 45:83–90. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Almangush A, Pirinen M, Heikkinen I,
Mäkitie AA, Salo T and Leivo I: Tumour budding in oral squamous
cell carcinoma: A meta-analysis. Br J Cancer. 118:577–586.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kassab A, Gupta I and Moustafa AEA: Role
of E2F transcription factor in oral cancer: Recent insight and
advancements. Semin Cancer Biol. 92:28–41. 2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Patel SB, Manjunatha BS, Shah V, Soni N
and Sutariya R: Immunohistochemical evaluation of p63 and cyclin D1
in oral squamous cell carcinoma and leukoplakia. J Korean Assoc
Oral Maxillofac Surg. 43:324–330. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yu HB, Glukhov E, Li Y, Iwasaki A, Gerwick
L, Dorrestein PC, Jiao BH and Gerwick WH: Cytotoxic microcolin
lipopeptides from the marine cyanobacterium moorea producens. J Nat
Prod. 82:2608–2619. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ramasubramanian A, Ramani P, Sherlin HJ,
Premkumar P, Natesan A and Thiruvengadam C: Immunohistochemical
evaluation of oral epithelial dysplasia using cyclin-D1, p27 and
p63 expression as predictors of malignant transformation. J Nat Sci
Biol Med. 4:349–358. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Xu Y, Yang X, Xiong Q, Han J and Zhu Q:
The dual role of p63 in cancer. Front Oncol.
13(1116061)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Johnson DE, Burtness B, Leemans CR, Lui
VWY, Bauman JE and Grandis JR: Head and neck squamous cell
carcinoma. Nat Rev Dis Primers. 6(92)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shah RB, Zhou M, LeBlanc M, Snyder M and
Rubin MA: Comparison of the basal cell-specific markers, 34betaE12
and p63, in the diagnosis of prostate cancer. Am J Surg Pathol.
26:1161–1668. 2002.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hibi K, Trink B, Patturajan M, Westra WH,
Caballero OL, Hill DE, Ratovitski EA, Jen J and Sidransky D: AIS is
an oncogene amplified in squamous cell carcinoma. Proc Natl Acad
Sci USA. 97:5462–5467. 2000.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Krishnamurthy S and Nör JE: Head and neck
cancer stem cells. J Dent Res. 91:334–340. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hendawy H, Esmail AD, Zahani AMN, Elmahdi
AH and Ibrahiem A: Clinicopathological correlation of stem cell
markers expression in oral squamous cell carcinoma; relation to
patients' outcome. J Immunoassay Immunochem. 42:571–595.
2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Boxberg M, Götz C, Haidari S, Dorfner C,
Jesinghaus M, Drecoll E, Boskov M, Wolff KD, Weichert W, Haller B
and Kolk A: Immunohistochemical expression of CD44 in oral squamous
cell carcinoma in relation to histomorphological parameters and
clinicopathological factors. Histopathology. 73:559–572.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chen W, Zhang X, Chu C, Cheung WL, Ng L,
Lam S, Chow A, Lau T, Chen M, Li Y, et al: Identification of CD44+
cancer stem cells in human gastric cancer. Hepatogastroenterology.
60:949–954. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hou Y, Zou Q, Ge R, Shen F and Wang Y: The
critical role of CD133(+)CD44(+/high) tumor cells in hematogenous
metastasis of liver cancers. Cell Res. 22:259–272. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R,
Hammond EH, Fu KK and Milas L: Impact of epidermal growth factor
receptor expression on survival and pattern of relapse in patients
with advanced head and neck carcinoma. Cancer Res. 62:7350–7356.
2002.PubMed/NCBI
|
|
27
|
Kimura I, Kitahara H, Ooi K, Kato K,
Noguchi N, Yoshizawa K, Nakamura H and Kawashiri S: Loss of
epidermal growth factor receptor expression in oral squamous cell
carcinoma is associated with invasiveness and
epithelial-mesenchymal transition. Oncol Lett. 11:201–207.
2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ribeiro PFA, Noguti J, Oshima CTF and
Ribeiro DA: Effective targeting of the epidermal growth factor
receptor (EGFR) for treating oral cancer: A promising approach.
Anticancer Res. 34:1547–1552. 2014.PubMed/NCBI
|
|
29
|
Wongpattaraworakul W, Gibson-Corley KN,
Choi A, Buchakjian MR, Lanzel EA, Rajan Kd A and Simons AL:
Prognostic role of combined egfr and tumor-infiltrating lymphocytes
in oral squamous cell carcinoma. Front Oncol.
12(885236)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kang JJ, Ko A, Kil SH, Mallen-St Clair J,
Shin DS, Wang MB and Srivatsan ES: EGFR pathway targeting drugs in
head and neck cancer in the era of immunotherapy. Biochim Biophys
Acta Rev Cancer. 1878(188827)2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
El-Naggar AK, Chan JKC, Takata T, Grandis
JR and Slootweg PJ: The fourth edition of the head and neck World
Health Organization blue book: Editors' perspectives. Hum Pathol.
66:10–12. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Pires FR, Ramos AB, de Oliveira JBC,
Tavares AS, de Luz PSR and dos Santos TCRB: Oral squamous cell
carcinoma: Clinicopathological features from 346 cases from a
single oral pathology service during an 8-year period. J Appl Oral
Sci. 21:460–467. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Pathak GS, Deshmukh SD and Ashturkar AV:
Construction of tissue arrays without prefabricated recipient
paraffin block experience of a novel technique in resource poor
settings. Indian J Pathol Microbiol. 54:654–655. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Singla S, Singla G, Zaheer S, Rawat DS and
Mandal AK: Expression of p53, epidermal growth factor receptor,
c-erbB2 in oral leukoplakias and oral squamous cell carcinomas. J
Cancer Res Ther. 14:388–393. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bugshan A and Farooq I: Oral squamous cell
carcinoma: Metastasis, potentially associated malignant disorders,
etiology and recent advancements in diagnosis. F1000Res.
9(229)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Shrestha G, Chang CP, Pun CB, Gautam DK,
Siwakoti B, Sapkota A and Hashibe M: Differences in risk factors
for head and neck cancer among men and women in Nepal: A
case-control study. Cancer Epidemiol. 82(102319)2023.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kashif M, Minhas S and Nagi AH: A
clinico-morphological study of oral squamous cell carcinoma in
Pakistan. Int J Curr Res. 7:17401–17405. 2015.
|
|
38
|
Khan SM, Prakash N, Mokashi RR, Gajdhar
SK, Sadhwani V and Manva MZ: Histopathological grades of oral
squamous cell carcinoma a prognostic indicator: Hospital-based
study. Int J Med Res Heal Sci. 11:17–22. 2022.
|
|
39
|
Saeed AS and Abdullah BH: The effect of
age on the clinicopathological features of oral squamous cell
carcinoma. J Baghdad Coll Dent. 34:25–28. 2022.
|
|
40
|
Bunget AM, Dascălu IT, Coleș E, Țîrcă T,
Stan M, Găman S and Nicola AG: Histopathological aspects in oral
squamous cell carcinoma. J Dent Sci. 3(000173)2018.
|
|
41
|
Bernardes VF, Gleber-Netto FO, de Sousa
SF, Rocha RM and De Aguiar MCF: EGFR status in oral squamous cell
carcinoma: Comparing immunohistochemistry, FISH and CISH detection
in a case series study. BMJ Open. 3(e002077)2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Warnakulasuriya S: Causes of oral
cancer-an appraisal of controversies. Br Dent J. 207:471–475.
2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Bello IO, Soini Y and Salo T: Prognostic
evaluation of oral tongue cancer: Means, markers and perspectives
(II). Oral Oncol. 46:636–643. 2010.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Nayak VN, Donoghue M and Selvamani M: Oral
squamous cell carcinoma: A 5 years institutional study. J Med
Radiol Pathol Surg. 1:3–6. 2015.
|
|
45
|
Zahir R, Khan ZA, Aleem B, Ahmad S, Ali A,
Issrani R, Alruwaili MK, Iqbal S, Alghumaiz SF, Alanazi SH, et al:
Association of high immunohistochemical expression of
minichromosome maintenance 3 with human oral squamous cell
carcinoma-a preliminary study. Diagnostics (Basel).
13(61)2023.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Shaikh AH, Muhammad T and Rasheed T:
Evaluating the correlation between histopathological patterns of
oral squamous cell carcinoma, age & site. Pak Oral Dent J.
35:30–32. 2015.
|
|
47
|
Yasin MM, Abbas Z and Hafeez A:
Correlation of histopathological patterns of OSCC patients with
tumor site and habits. BMC Oral Health. 22(305)2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Matsubara R, Kawano S, Kiyosue T, Goto Y,
Hirano M, Jinno T, Toyoshima T, Kitamura R, Oobu K and Nakamura S:
Increased ΔNp63 expression is predictive of malignant
transformation in oral epithelial dysplasia and poor prognosis in
oral squamous cell carcinoma. Int J Oncol. 39:1391–1399.
2011.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Lo Muzio L, Santarelli A, Caltabiano R,
Rubini C, Pieramici T, Trevisiol L, Carinci F, Leonardi R, De Lillo
A, Lanzafame S, et al: p63 overexpression associates with poor
prognosis in head and neck squamous cell carcinoma. Hum Pathol.
36:187–194. 2005.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Saghravanian N, Anvari K, Ghazi N, Memar
B, Shahsavari M and Aghaee MA: Expression of p63 and CD44 in oral
squamous cell carcinoma and correlation with clinicopathological
parameters. Arch Oral Biol. 82:160–165. 2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Sri Gowri M, Sagar P, Prasad K, Vanishree
Shridhar P and Rao R: Expression of CD44 and its
clinicopathological correlation in oral squamous cell carcinoma: An
immunohistochemical study. Acta Sci Otolaryngol. 6:5–13. 2024.
|
|
52
|
Oncel S, Cosgul T, Calli A, Calli C and
Pinar E: Evaluation of p53, p63, p21, p27, ki-67 in paranasal sinus
squamous cell carcinoma and inverted papilloma. Indian J
Otolaryngol Head Neck Surg. 63:172–177. 2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Bavle RM, Paremala K, Soumya M, Reshma V
and Sudhakara M: Immunohistochemical expression of p63 in oral
premalignant disorders and its correlation with oral squamous cell
carcinoma. J Datta Meghe Inst Med Sci Univ. 15:255–260. 2020.
|
|
54
|
Yugawa T, Narisawa-Saito M, Yoshimatsu Y,
Haga K, Ohno SI, Egawa N, Fujita M and Kiyono T: DeltaNp63alpha
repression of the Notch1 gene supports the proliferative capacity
of normal human keratinocytes and cervical cancer cells. Cancer
Res. 70:4034–4044. 2010.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Nguyen BC, Lefort K, Mandinova A, Antonini
D, Devgan V, Della Gatta G, Koster MI, Zhang Z, Wang J, Tommasi di
Vignano A, et al: Cross-regulation between Notch and p63 in
keratinocyte commitment to differentiation. Genes Dev.
20:1028–1042. 2006.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Yang A and McKeon F: P63 and P73: P53
mimics, menaces and more. Nat Rev Mol Cell Biol. 1:199–207.
2000.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Graziano V and De Laurenzi V: Role of p63
in cancer development. Biochim Biophys Acta. 1816:57–66.
2011.PubMed/NCBI View Article : Google Scholar
|
|
58
|
de Oliveira LR, Ribeiro-Silva A and
Zucoloto S: Prognostic impact of p53 and p63 immunoexpression in
oral squamous cell carcinoma. J Oral Pathol Med. 36:191–197.
2007.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Dayakar A, Shetty P and Dayakar MM: The
expression of p63 protein in different grades of oral squamous cell
carcinoma-an immunohistochemical study. J Evol Med Dent Sci.
8:3332–3336. 2019.
|
|
60
|
Loljung L, Coates PJ, Nekulova M, Laurell
G, Wahlgren M, Wilms T, Widlöf M, Hansel A and Nylander K: High
expression of p63 is correlated to poor prognosis in squamous cell
carcinoma of the tongue. J Oral Pathol Med. 43:14–19.
2014.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Califano J, van der Riet P, Westra W,
Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B,
Koch W and Sidransky D: Genetic progression model for head and neck
cancer: Implications for field cancerization. Cancer Res.
56:2488–2492. 1996.PubMed/NCBI
|
|
62
|
Alkhatib DZR, Truong TTK, Fujii S,
Hasegawa K, Nagano R, Tajiri Y and Kiyoshima T: Stepwise activation
of p63 and the MEK/ERK pathway induces the expression of ARL4C to
promote oral squamous cell carcinoma cell proliferation. Pathol Res
Pract. 246(154493)2023.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Fonseca I, Pereira T, Rosa-Santos J and
Soares J: Expression of CD44 isoforms in squamous cell carcinoma of
the border of the tongue: A correlation with histological grade,
pattern of stromal invasion, and cell differentiation. J Surg
Oncol. 76:115–120. 2001.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Kanke M, Fujii M, Kameyama K, Kanzaki J,
Tokumaru Y, Imanishi Y, Tomita T and Matsumura Y:
Clinicopathological significance of expression of CD44 variants in
head and neck squamous cell carcinoma. Jpn J Cancer Res.
91:410–415. 2000.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Poothakulath Krishnan R, Pandiar D, Ramani
P, Ramalingam K and Jayaraman S: Utility of CD44/CD24 in the
outcome and prognosis of oral squamous cell carcinoma: A systematic
review. Cureus. 18(e42899)2023.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Carinci F, Stabellini G, Calvitti M,
Pelucchi S, Targa L, Farina A, Pezzetti F and Pastore A: CD44 as
prognostic factor in oral and oropharyngeal squamous cell
carcinoma. J Craniofac Surg. 13:85–89. 2002.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Du T, Wu Z, Wu Y, Liu Y, Song Y and Ma L:
CD44 is associated with poor prognosis of ccRCC and facilitates
ccRCC cell migration and invasion through HAS1/MMP9. Biomedicines.
11(2077)2023.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Thapa R and Wilson GD: The importance of
CD44 as a stem cell biomarker and therapeutic target in cancer.
Stem Cells Int. 2016(2087204)2016.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Yuan SSF, Hung AC, Hsu CW, Lan TH, Su CW,
Chi TC, Chang YC, Chen YK and Wang YY: CD44 mediates oral squamous
cell carcinoma-promoting activity of MRE11 via AKT signaling. J
Pers Med. 12(841)2022.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Qiao X, Zhu L, Song R, Shang C and Guo Y:
CD44 occurring alternative splicing promotes cisplatin resistance
and evokes tumor immune response in oral squamous cell carcinoma
cells. Transl Oncol. 31(101644)2023.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Essa AAM and Deraz EM: Expression of CD44
(NKI-P1) in oral squamous cell carcinoma associated vascular
endothelial cells: A relationship to tumor angiogenesis. Saudi Dent
J. 34:21–26. 2022.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia
W, Wei Y, Bartholomeusz G, Shih JY and Hung MC: Nuclear interaction
of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer
Cell. 7:575–589. 2005.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Kappler M, Dauter K, Reich W, Bethmann D,
Schwabe M, Rot S, Wickenhauser C, Al-Nawas B and Eckert AW:
Prognostic impact of cytoplasmatic EGFR upregulation in patients
with oral squamous cell carcinoma: A pilot study. Mol Clin Oncol.
13(88)2020.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Verma J, Dhingra V, Srivastava S, Misra V,
Varma K and Singh S: Alteration of cellular metabolism in cancer
cells and its therapeutic. J Oral Maxillofac Pathol. 21:244–251.
2017.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Taguchi T: Nuclear translocation of
epidermal growth factor receptor and its relation to
clinicopathological factors in oral squamous cell carcinomas.
Kokubyo Gakkai Zasshi. 81:45–52. 2014.PubMed/NCBI(In Japanese).
|
|
76
|
Cheng Y, Song Z, Chen J, Tang Z and Wang
B: Molecular basis, potential biomarkers, and future prospects of
OSCC and PD-1/PD-L1 related immunotherapy methods. Heliyon.
10(e25895)2024.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Gou Q, Dong C, Xu H, Khan B, Jin J, Liu Q,
Shi J and Hou Y: PD-L1 degradation pathway and immunotherapy for
cancer. Cell Death Dis. 11(955)2020.PubMed/NCBI View Article : Google Scholar
|
|
78
|
González-Moles MÁ, Warnakulasuriya S,
López-Ansio M and Ramos-García P: Hallmarks of cancer applied to
oral and oropharyngeal carcinogenesis: A scoping review of the
evidence gaps found in published systematic reviews. Cancers
(Basel). 14(3834)2022.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Biswal BN, Das SN, Das BK and Rath R:
Alteration of cellular metabolism in cancer cells and its
therapeutic prospects. J Oral Maxillofac Pathol. 21:244–251.
2017.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Pierobon M, Wulfkuhle J, Liotta LA and
Petricoin Iii EF: Utilization of proteomic technologies for
precision oncology applications. Cancer Treat Res. 178:171–187.
2019.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Cívico-Ortega JL, González-Ruiz I,
Ramos-García P, Cruz-Granados D, Samayoa-Descamps V and
González-Moles MÁ: Prognostic and clinicopathological significance
of epidermal growth factor receptor (EGFR) expression in oral
squamous cell carcinoma: Systematic review and meta-analysis. Int J
Mol Sci. 24(11888)2023.PubMed/NCBI View Article : Google Scholar
|
